ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-23 |

Results: 23

OLANZAPINE IN THE TREATMENT OF SCHIZOAFFECTIVE DISORDER

Authors: TRAN P LU Y SANGER T BEASLEY C TOLLEFSON G

Citation: P. Tran et al., OLANZAPINE IN THE TREATMENT OF SCHIZOAFFECTIVE DISORDER, Schizophrenia research, 29(1-2), 1998, pp. 151-151

SAFETY OF ABRUPT DISCONTINUATION OF FLUOXETINE - A RANDOMIZED, PLACEBO-CONTROLLED STUDY

Authors: ZAJECKA J FAWCETT J AMSTERDAM J QUITKIN F REIMHERR F ROSENBAUM J MICHELSON D BEASLEY C

Citation: J. Zajecka et al., SAFETY OF ABRUPT DISCONTINUATION OF FLUOXETINE - A RANDOMIZED, PLACEBO-CONTROLLED STUDY, Journal of clinical psychopharmacology, 18(3), 1998, pp. 193-197

DONOR ACTION - A SYSTEMATIC-APPROACH TO ORGAN DONATION

Authors: WIGHT C COHEN B BEASLEY C MIRANDA B DEBLANDER G

Citation: C. Wight et al., DONOR ACTION - A SYSTEMATIC-APPROACH TO ORGAN DONATION, Transplantation proceedings, 30(5), 1998, pp. 2253-2254

LOOKING FOR PELTIER,LEONARD (THE AMERICAN-INDIAN MOVEMENT ACTIVIST, WHO CONTINUES TO LANGUISH IN THE FEDERAL PENITENTIARY IN LEAVENWORTH, KANSAS, VICTIM OF A RIGGED TRIAL BY FBI PROSECUTORS IN THE LATE 1970S)

Authors: BEASLEY C

Citation: C. Beasley, LOOKING FOR PELTIER,LEONARD (THE AMERICAN-INDIAN MOVEMENT ACTIVIST, WHO CONTINUES TO LANGUISH IN THE FEDERAL PENITENTIARY IN LEAVENWORTH, KANSAS, VICTIM OF A RIGGED TRIAL BY FBI PROSECUTORS IN THE LATE 1970S), The North American review, 283(3-4), 1998, pp. 64-71

USE OF PATTERN-ANALYSIS TO PREDICT DIFFERENTIAL RELAPSE OF REMITTED PATIENTS WITH MAJOR DEPRESSION DURING 1 YEAR OF TREATMENT WITH FLUOXETINE OR PLACEBO

Authors: STEWART JW QUITKIN FM MCGRATH PJ AMSTERDAM J FAVA M FAWCETT J REIMHERR F ROSENBAUM J BEASLEY C ROBACK P

Citation: Jw. Stewart et al., USE OF PATTERN-ANALYSIS TO PREDICT DIFFERENTIAL RELAPSE OF REMITTED PATIENTS WITH MAJOR DEPRESSION DURING 1 YEAR OF TREATMENT WITH FLUOXETINE OR PLACEBO, Archives of general psychiatry, 55(4), 1998, pp. 334-343

QUALITY-OF-LIFE OUTCOMES FOR OLANZAPINE AND HALOPERIDOL TREATMENT FORSCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS - RESULTS OF AN INTERNATIONAL CLINICAL-TRIAL

Authors: REVICKI D HALEY J HAMILTON S GENDUSO L BEASLEY C

Citation: D. Revicki et al., QUALITY-OF-LIFE OUTCOMES FOR OLANZAPINE AND HALOPERIDOL TREATMENT FORSCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS - RESULTS OF AN INTERNATIONAL CLINICAL-TRIAL, Quality of life research, 6(7-8), 1997, pp. 315-315

OLANZAPINE VS CHLORPROMAZINE IN THERAPY-REFRACTORY SCHIZOPHRENIA

Authors: CONLEY RR TAMMINGA CA BEASLEY C

Citation: Rr. Conley et al., OLANZAPINE VS CHLORPROMAZINE IN THERAPY-REFRACTORY SCHIZOPHRENIA, Schizophrenia research, 24(1-2), 1997, pp. 190-190

OLANZAPINE PLASMA-CONCENTRATIONS AND CLINICAL-RESPONSE IN ACUTELY ILLSCHIZOPHRENIC-PATIENTS

Authors: PERRY PJ SANGER T BEASLEY C

Citation: Pj. Perry et al., OLANZAPINE PLASMA-CONCENTRATIONS AND CLINICAL-RESPONSE IN ACUTELY ILLSCHIZOPHRENIC-PATIENTS, Journal of clinical psychopharmacology, 17(6), 1997, pp. 472-477

DOUBLE-BLIND COMPARISON OF OLANZAPINE VERSUS RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS

Authors: TRAN PV HAMILTON SH KUNTZ AJ POTVIN JH ANDERSEN SW BEASLEY C TOLLEFSON GD

Citation: Pv. Tran et al., DOUBLE-BLIND COMPARISON OF OLANZAPINE VERSUS RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS, Journal of clinical psychopharmacology, 17(5), 1997, pp. 407-418

ABRUPT DISCONTINUATION OF FLUOXETINE - A RANDOMIZED, PLACEBO-CONTROLLED STUDY

Authors: MICHELSON D ONAWOLA R BEASLEY C

Citation: D. Michelson et al., ABRUPT DISCONTINUATION OF FLUOXETINE - A RANDOMIZED, PLACEBO-CONTROLLED STUDY, Psychopharmacology bulletin, 33(3), 1997, pp. 556-556

OLANZAPINE VS CHLORPROMAZINE IN TREATMENT-RESISTANT SCHIZOPHRENIA

Authors: CONLEY RR TAMMINGA CA BEASLEY C

Citation: Rr. Conley et al., OLANZAPINE VS CHLORPROMAZINE IN TREATMENT-RESISTANT SCHIZOPHRENIA, Biological psychiatry, 41, 1997, pp. 246-246

ABRUPT DISCONTINUATION OF FLUOXETINE - A RANDOMIZED, PLACEBO-CONTROLLED STUDY

Authors: MICHELSON D ONAWOLA R BEASLEY C

Citation: D. Michelson et al., ABRUPT DISCONTINUATION OF FLUOXETINE - A RANDOMIZED, PLACEBO-CONTROLLED STUDY, Biological psychiatry, 41, 1997, pp. 332-332

QUALITY-OF-LIFE OUTCOMES OF OLANZAPINE, A NEW ATYPICAL ANTIPSYCHOTIC AGENT

Authors: MARTIN C GENDUSO L REVICKI D HAMILTON S TRAN P BEASLEY C

Citation: C. Martin et al., QUALITY-OF-LIFE OUTCOMES OF OLANZAPINE, A NEW ATYPICAL ANTIPSYCHOTIC AGENT, Schizophrenia research, 18(2-3), 1996, pp. 1-1

CHARTING AN OTHER DIRECTION - SEXUAL ECONOMYTHS AND SUGGESTIONS FOR AFEMINIST ECONOMICS/

Authors: BEASLEY C

Citation: C. Beasley, CHARTING AN OTHER DIRECTION - SEXUAL ECONOMYTHS AND SUGGESTIONS FOR AFEMINIST ECONOMICS/, Australian feminist studies, 11(23), 1996, pp. 99-113

OLANZAPINE VERSUS HALOPERIDOL - ACUTE RESULTS OF THE MULTICENTER INTERNATIONAL TRIAL

Authors: TOLLEFSON G BEASLEY C TRAN P DELLVA MA KRUEGER J TAMURA R

Citation: G. Tollefson et al., OLANZAPINE VERSUS HALOPERIDOL - ACUTE RESULTS OF THE MULTICENTER INTERNATIONAL TRIAL, Psychopharmacology bulletin, 32(3), 1996, pp. 401-401

EFFECTIVENESS OF OLANZAPINE IN LONG-TERM CONTINUATION TREATMENT

Authors: SATTERLEE W DELLVA MA BEASLEY C TRAN P TOLLEFSON O

Citation: W. Satterlee et al., EFFECTIVENESS OF OLANZAPINE IN LONG-TERM CONTINUATION TREATMENT, Psychopharmacology bulletin, 32(3), 1996, pp. 509-509

OLANZAPINE IN THE TREATMENT OF SCHIZOAFFECTIVE DISORDER

Authors: TRAN P LU YL SANGER T BEASLEY C TOLLEFSON G

Citation: P. Tran et al., OLANZAPINE IN THE TREATMENT OF SCHIZOAFFECTIVE DISORDER, Psychopharmacology bulletin, 32(3), 1996, pp. 527-527

'IN THE BELLY OF THE BEAST'

Authors: BEASLEY C

Citation: C. Beasley, 'IN THE BELLY OF THE BEAST', The North American review, 281(3), 1996, pp. 10-14

A COMPARISON OF RECOMBINANT HIRUDIN WITH HEPARIN FOR THE TREATMENT OFACUTE CORONARY SYNDROMES

Authors: TOPOL EJ CALIFF R GRANGER C VANDEWERF F AYLWARD P SIMES J COL J ARMSTRONG P VAHANIAN A NEUHAUS K RUTSCH W ARDISSINO D SIMOONS M WHITE H BETRIU A EMANUELSSON H PFISTERER M BEATT K BATES E CHESEBORO J ELLIS S FUSTER V GIBLER W GORE J GUERCI A HOCHMAN J HOLMES D KLEIMAN N MORRIS D OHMAN M PHILLIPS H WEAVER D LEE K WOODLEAF L MILLER G BAHR R WORLEY S SCHRADING W GILCHRIST I IBARRA J KRISHNASWAMI V NYGAARD T DAGEFORDE D PUMA J PALMERI S ROSING D DALE H BOYEK T MORRICE B WEINBERG S NOBLE W VANGILDER J OTOOLE J JESSE R LOSS D WERTHEIMER J FERRARI D SANTER M STRAHAN N SCHAEFFER J AVEINGTON M MILLER R EICH D VROBEL T KERIEAKES D SHARMA S BECKWITH W MICALE P POLINSKI W GOODFIELD P PARASCHOS A CHANDLER A TALLEY J MORSE H SHERIDAN F SILVERMAN M BAGA V WARE J SEAGLE R MADDOX W SCHRANK J GAINEY P MORRIS D IWAOKA R SCHNEIDER R INGRAM R HANGER K LANE G BEESON W WILLIAMS D BEASLEY C SPRIGGS D SCHLANT R SULLEBARGER J SMITH J MISHKEL D WILLIAMS C GIBBS K HEARON B GONZALES M SHEIKH K DEDONIS J LONG T POPIO K JAMAL N LAMBREW C LABIB S VORCHHEIMER D WEISS R MERCADANTE N GUEREI A RASHKOW A BALLELI L GACIOCH G NILES N SEIDENSTEIN H HOLLANDER G WALLACH R KHAN A GRAHAM S SIMONS A WARD H PARKES R WATKINS M DELUCCIA W URBACH D GRODMAN R MCCORD D BLEIBERG M CORBELLI J PEPE A ZWERNER P PINSKY L PETROVICH L LINDENBERG B THERRIEN M SANDS M ROSENFELD A SHEIKH S RIBA A HANOVICH G SWENSON L HOLLAND K SCHMIDT P BESLEY D HESSION W FERRIGNI F MEYERS D DUVERNOY W ABRAMOWITZ B STOMEL R BECKER J MOOSS A THOMPSON J CALLI L PENILLA A MCCRISKIN J MILLSAPS R HEINSIMER J PFEFFERKORN D SADDIN M FINTEL D HARNER R KOPECKY S ANDRES P COOK L WEFALD F VANDERLAAN R LOVE J ZANDS M SANTOLIN C ARNOLD A OATFIELD R JAEGER K DEAN E SWENSON R LANCASTER L RASKIN S FEHRENBACHER G LOMBARDO T STRUNK B PERRY J LAI P ROWE W SYMKOVIAK G LEE H KWEE H WOOLBERT S MILLER R KAPLAN J TITUS B WOLFE C CISLOWSKI D BERNDT T WHITE R BROWN D HILL D HUI G SPIEGEL R WESLEY G MATTERN A LAPIN E STERN M KRAUS M OLSON H SCOTT R MACKENZIE B HUI W ROTH S GOODE E BURTON J SENARATNE M TRABOULSI M GREENWOOD P MORGAN C ERVIN F MCDOWELL J LEFKOWITZ C SAUVE M TUREK M FINNIE K KURUVILLA G LANGE A CHARLES J KELLS C VIZEL S BAILLIE H SAHAY B ROTH D LUBELSKY B JABLONSKY G LESOWAY R KOWK K MACMILLAN C ADELMLAN A LABINAZ M GUAGLIUMI G BRANZI A GALVANI M MAFRICI A SAVONITTO S FORNARO G COLOMBI E ZANUTTINI D OTTANI F CAVALLINI C CAMERINI F REPETTO S VASSANELLI C ROVELLI E POLESE A POLITI A CAPUCCI A MAMBELLI M SABATE X MASIA R BESCOS LL SENDON JL JODAR L RODRIQUEZLLORIAN A MARTINLUENGO C SAENZ L FERNANDEZAVILES F FROUFE J LOMAOSORIO A BAYON J JEFFREY I NELSON G WALSH W LEITCH J CAMPBELL T HEALEY J OWENSBY D RAMSEY D GRIGG L FERDERMAN J NEWMAN R STRICKLAND J LIM P COUNSELL J CROSS D GARRAHY P COVERDALE S BETT N ARONCY G BROWN M SIMMONS G HOROWITZ J THOMPSON P HOCKINGS B HENDRICKS R THOMSON A RANKIN R BOUMA H COZYNSEN L STOLWIJK P DROST H VANKALMTHOUT P ENGBERS J WESTENDORP P VOORBURG J VEERHOEK M PAOHAN T BOGERIJEN L MISIER AR BOSKER H SMITS W TAN T CASTADOT M INSTALLE E DEMEESTER A BOLAND J LEGRAND V VANWELDEN J PIRENNE B EMMERECHTS C BEEUWSAERT R THIELS H BECKERS J LESSELIERS H POPEYE R QUIRET J MARONI J FARAH B ETIENNE Y FUNCK F THANK XT KHALIFE K LECLERCQ F VITOUX B COHEN A VACHERON A BARREAU D SIMON R KREFT H DITTER H ZEIHER A WEIZNER M WACKER R MARBACH M NAST H MEYERHOFMANN H SCHMITZHUBNER U BODE M MAISCH B TOPP H RUTSCH W LOLLGEN H WILLIAMS M DURHAM D BRUNS B HAYES D LESLIE P HART H IKRAM H MANN S KIRK A JARDINE D RANKIN R AUDEAU M ANANDARAJA S COOPER I HOGAN J HACKETT D TRAVILL C BRIDGON G BURRELL C DEBELDER M ROZKOVEC A KOONER J JAMES M GARCIA E RISENFORS M PFISTERER M BAUR H URBAN P MOCETTI T ANGEHRN W BERTEL O AMANN F

Citation: Ej. Topol et al., A COMPARISON OF RECOMBINANT HIRUDIN WITH HEPARIN FOR THE TREATMENT OFACUTE CORONARY SYNDROMES, The New England journal of medicine, 335(11), 1996, pp. 775-782

OLANZAPINE, A NEW ATYPICAL ANTIPSYCHOTIC

Authors: SATTERLEE W BEASLEY C SANGER T TRAN P TOLLEFSON G

Citation: W. Satterlee et al., OLANZAPINE, A NEW ATYPICAL ANTIPSYCHOTIC, Schizophrenia research, 15(1-2), 1995, pp. 163-164

ADDITIONAL CLINICAL-EXPERIENCE WITH OLANZAPINE, AN ATYPICAL ANTIPSYCHOTIC

Authors: SATTERLEE W BEASLEY C SANGER T TOLLEFSON G

Citation: W. Satterlee et al., ADDITIONAL CLINICAL-EXPERIENCE WITH OLANZAPINE, AN ATYPICAL ANTIPSYCHOTIC, Schizophrenia research, 15(1-2), 1995, pp. 163-163

OPTIONS FOR INCREASING ORGAN DONATION - THE POTENTIAL ROLE OF FINANCIAL INCENTIVES, STANDARDIZED HOSPITAL PROCEDURES, AND PUBLIC-EDUCATION TO PROMOTE FAMILY DISCUSSION

Authors: DEJONG W DRACHMAN J GORTMAKER SL BEASLEY C EVANISKO MJ

Citation: W. Dejong et al., OPTIONS FOR INCREASING ORGAN DONATION - THE POTENTIAL ROLE OF FINANCIAL INCENTIVES, STANDARDIZED HOSPITAL PROCEDURES, AND PUBLIC-EDUCATION TO PROMOTE FAMILY DISCUSSION, The Milbank quarterly, 73(3), 1995, pp. 463-479

CLINICAL EFFICACY OF BION-TEARS(TM), CELLUFRESH(TM) AND AQUASITE(TM) IN MODERATE TO SEVERE DRY EYE PATIENTS

Authors: WOLF T MCCULLEY J BEASLEY C SCOPER S NELSON J

Citation: T. Wolf et al., CLINICAL EFFICACY OF BION-TEARS(TM), CELLUFRESH(TM) AND AQUASITE(TM) IN MODERATE TO SEVERE DRY EYE PATIENTS, Investigative ophthalmology & visual science, 35(4), 1994, pp. 1694-1694

Risultati: 1-23 |